Immatics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immatics and other ETFs, options, and stocks.

About IMTX

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. 

CEO
Harpreet Singh-Jasuja
CEOHarpreet Singh-Jasuja
Employees
423
Employees423
Headquarters
Tuebingen, Baden Wuerttemberg
HeadquartersTuebingen, Baden Wuerttemberg
Founded
2020
Founded2020
Employees
423
Employees423

IMTX Key Statistics

Market cap
653.94M
Market cap653.94M
Price-Earnings ratio
-23.52
Price-Earnings ratio-23.52
Dividend yield
Dividend yield
Average volume
832.44K
Average volume832.44K
High today
$5.49
High today$5.49
Low today
$5.23
Low today$5.23
Open price
$5.43
Open price$5.43
Volume
831.36K
Volume831.36K
52 Week high
$13.09
52 Week high$13.09
52 Week low
$3.30
52 Week low$3.30

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own IMTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.